Back to discover
Disease

Sexual dysfunction

Late-stage therapeutic development
16
Clinical trials
1
Associated genes
1
Related proteins

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Executive briefingUpdating summary…Momentum: Low
Key developments
  • 1 clinical trial expected to report results, the earliest in Q4 2026.
Major developments
Upcoming trial readoutHigh impact
Results expected Q4 20262026-07-23
Clinical Milestones1View

Therapeutic landscape

Therapies with a regulatory footing for this condition, alongside the wider set of agents co-studied with it in the literature.

Approved & established therapies
Tadalafilapproved

Approval — Treatment of erectile dysfunction in adult males.In order for tadalafil to be effective,… (2017)

Avanafilapproved

Approval — Treatment of erectile dysfunction in adult men. In order for Spedra to be effective, sexu… (2013)

Sildenafilapproved

Approval — Treatment of men with erectile dysfunction, which is the inability to achieve or maintain… (2009)

Vardenafilapproved

Approval — Treatment of erectile dysfunction in adult men. Erectile dysfunction is the inability to… (2003)

Clinical trials

13 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
16
All trials
3
Active
13
Late-stage
6
Completed
Late-stage studies
Recently completed

Regulatory timeline

Drug regulatory events matched to this condition by indication — EMA.

First approvals
2017emaApprovalTadalafil· Treatment of erectile dysfunction in adult males.In order for tadalafil to be effective, sexual stimulation is required. Tadalafil Lilly is not indicated for use by women. Treatment of the signs and symptoms of benign prostatic hyperplasia in adult males. source ↗
2014emaApprovalTadalafil· Treatment of erectile dysfunction in adult males. In order for tadalafil to be effective, sexual stimulation is required. Tadalafil Mylan is not indicated for use by women. source ↗
2013emaApprovalAvanafil· Treatment of erectile dysfunction in adult men. In order for Spedra to be effective, sexual stimulation is required. source ↗
2009emaApprovalSildenafil· Treatment of men with erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. In order for Sildenafil Actavis to be effective, sexual stimulation is required. source ↗
2003emaApprovalVardenafil· Treatment of erectile dysfunction in adult men. Erectile dysfunction is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. In order for Levitra to be effective, sexual stimulation is required. Levitra is not indicated for use by women. source ↗
2002emaApprovalTadalafil· Treatment of erectile dysfunction. In order for tadalafil to be effective, sexual stimulation is required. Cialis is not indicated for use by women. source ↗
1998emaApprovalSildenafil· Treatment of men with erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. In order for Viagra to be effective, sexual stimulation is required. source ↗

European Medicines Agency (CC BY 4.0). Events are matched to this condition by drug indication text — approvals/updates for drugs indicated for it, not disease-specific acts.

Associated genes

1 match

Genes associated with this disease in the canonical knowledge graph (Open Targets evidence). Number shows the association score.

Disease biology

1 match

Proteins whose encoding gene is associated with this disease, reached through the canonical gene→disease graph. Number shows the gene's association score.

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.